TQC3927 powder for inhalation

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Chronic Obstructive Pulmonary Disease

Phase 1

A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects

CompletedNCT06408285

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Obstructive Pulmonary Disease

Start: 2024-05-22End: 2024-08-19Updated: 2024-10-29

A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease

CompletedNCT06711991

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Obstructive Pulmonary Disease

Start: 2025-02-11End: 2025-08-11Updated: 2025-08-15